Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 146 | 163 | 155 | 152 | 152 |
| Accounts payable and accrued liabilities | -555 | 69 | -1,284 | 1,306 | -563 |
| Other Working Capital | -679 | -1,547 | 1,419 | 2,457 | -813 |
| Other Operating Activity | -8,557 | -14,729 | -8,349 | -12,740 | -9,152 |
| Operating Cash Flow | $-9,645 | $-16,044 | $-8,059 | $-8,825 | $-10,376 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -14 | -181 | 0 | -17 |
| Purchase Of Investment | N/A | -19,996 | -4 | N/A | -19,995 |
| Sale Of Investment | 7,505 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 4,999 | 0 |
| Investing Cash Flow | $7,505 | $-20,010 | $-185 | $4,999 | $-20,012 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 36 | 0 | N/A | N/A |
| Other Financing Activity | 15 | 30 | 0 | 85 | 75 |
| Financing Cash Flow | $15 | $66 | $0 | $85 | $75 |
| Exchange Rate Effect | 2 | 7 | -4 | 1 | 3 |
| Beginning Cash Position | 39,114 | 75,095 | 83,343 | 87,083 | 117,393 |
| End Cash Position | 36,991 | 39,114 | 75,095 | 83,343 | 87,083 |
| Net Cash Flow | $-2,125 | $-35,988 | $-8,244 | $-3,741 | $-30,313 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,645 | -16,044 | -8,059 | -8,825 | -10,376 |
| Capital Expenditure | N/A | -14 | -181 | N/A | -17 |
| Free Cash Flow | -9,645 | -16,058 | -8,240 | -8,825 | -10,393 |